Year reported gender age Period (years) between PM/DM and crescentic glomerulonephritis Level of MPO (EU) outcome
1999(5) female 54 3 420 uremia
2003(6) female 39 10 149 uremia
2011(4) male 60 10 1280 uremia
2013 (present study) male 72 concurrent 109.2 uremia
Table 1: MPO-related crescentic glomerulonephritis in polymyositis/dermatomyositis